Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N970012/S210

AMS 700 Inflatable Penile Prosthesis with and without InhibiZone

Boston Scientific Corp · Decision date Oct 2, 2025

FDA DECISIONN970012/S210

What did the FDA decide?

FDA records N970012/S210 as a supplement to PMA null, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 2, 2025.

FDA approval order statement

changes for the pump to kink resistant tubing bonding process preparation and equipment for TENACIO Pump components at Boston Scientific Corporation (BSC) St. Paul
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 2, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
N970012/S210
Regulatory pathway
PMA supplement
Product code
JCW
Decision code
OK30
Decision date
Oct 2, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, penis, inflatable.

Product code
JCW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N970012/S210 received

    Application receipt date recorded by FDA.

  2. N970012/S210 · FDA decision

    30-Day Notice

Related devices and submissions

Explore the linked device profile

Other records with product code JCW

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementSep 14, 2026FDA
Boston Scientific CorpPMA supplementMay 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
100 Boston Scientific Way, Marlboro, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records